SLStephen LocarniniBSc(Hons), PhD, MBBS, FRC(Path)VideoViral Hepatitis and Liver DiseaseHEP DART 2017Endpoints and New Targets for Curing Hepatitis B | Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)View Video
SLStephen LocarniniBSc(Hons), PhD, MBBS, FRC(Path)VideoViral Hepatitis and Liver DiseaseHEP DART 2017Is Host Genome Integrated HBV Relevant? - The Con Perspective | Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)View Video
MPMarion PetersMDVideoViral Hepatitis and Liver DiseaseHEP DART 2017Personalized Approaches to HBV Cure | Marion Peters, MDView Video
AGAdam GehringPhDVideoViral Hepatitis and Liver DiseaseHEP DART 2017Immunology of HBV | Adam Gehring, PhDView Video
VideoViral Hepatitis and Liver DiseaseHEP DART 2017Short Duration DAA HCV Therapy: How Short Can We Go? | Shyam Kottilil, MD, PhDView Video
VideoViral Hepatitis and Liver DiseaseHEP DART 2017DAA Therapy and Reinfection Among People who Inject Drugs: Forming a Foundation for HCV Elimination | Jason GrebelyView Video
VideoViral Hepatitis and Liver DiseaseHEP DART 2017Liver Disease in Chinese-perspective from a Hepatologist | George Lau, MBBS, MRCP, FHKCP, FHKAM, MD, FRCPView Video
VideoViral Hepatitis and Liver DiseaseHEP DART 2017Access to HIV, HBV, and HCV Antiviral Agents Globally | John Martin, PhDView Video
VideoViral Hepatitis and Liver DiseaseHEP DART 2017Global Strategies to Eliminate Hepatitis B (ICE-HBV) | Peter RevillView Video
VideoViral Hepatitis and Liver DiseaseHEP DART 2017Consensus AASLD-EASL HBV Treatment Endpoint and HBV Cure Definition | Anna S. Lok, MD, DScView Video
VideoViral Hepatitis and Liver DiseaseHEP DART 2017The French and European Approach Towards Hepatitis Elimination | Tarik Asselah, MD, PhDView Video
VideoViral Hepatitis and Liver DiseaseHEP DART 2017Elimination of HCV: The DC Story | Henry Masur, MDView Video
